Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Liebowitz

Showing results (121-130 of 228) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Psychiatry|March 1, 1990
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatmentE Hollander, C M DeCaria, F R Schneier, et al.
The American Journal of Psychiatry|March 4, 2000
Low dopamine D(2) receptor binding potential in social phobiaF R Schneier, M R Liebowitz, A Abi-Dargham, et al.
Psychopharmacology Bulletin|January 1, 1996
The pharmacotherapy of hypochondriasisB A Fallon, F R Schneier, R Marshall, et al.
Psychopharmacology Bulletin|January 1, 1990
Phenelzine and atenolol in social phobiaM R Liebowitz, F Schneier, R Campeas, et al.
Psychosomatics|May 1, 1995
Late-stage neuropsychiatric Lyme borreliosis. Differential diagnosis and treatmentB A Fallon, M Schwartzberg, R Bransfield, et al.
The American Journal of Psychiatry|June 1, 1988
Epinephrine infusions in patients with social phobiaL A Papp, J M Gorman, M R Liebowitz, et al.
Journal of Clinical Psychopharmacology|June 1, 1990
Anxiety and depression: discrete diagnostic entities?M R Liebowitz, E Hollander, F Schneier, et al.
Biological Psychiatry|May 15, 1993
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorderE Hollander, D J Stein, C M DeCaria, et al.
The Journal of Nervous and Mental Disease|August 1, 1991
Cognitive-behavior therapy for panic disorder delivered by psychopharmacologically oriented cliniciansL A Welkowitz, L A Papp, M Cloitre, et al.
Biological Psychiatry|May 1, 1985
Biochemical effects of L-deprenyl in atypical depressivesM R Liebowitz, F Karoum, F M Quitkin, et al.
Pageof 23

Showing results (121-130 of 228) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Psychiatry|March 1, 1990
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatmentE Hollander, C M DeCaria, F R Schneier, et al.
The American Journal of Psychiatry|March 4, 2000
Low dopamine D(2) receptor binding potential in social phobiaF R Schneier, M R Liebowitz, A Abi-Dargham, et al.
Psychopharmacology Bulletin|January 1, 1996
The pharmacotherapy of hypochondriasisB A Fallon, F R Schneier, R Marshall, et al.
Psychopharmacology Bulletin|January 1, 1990
Phenelzine and atenolol in social phobiaM R Liebowitz, F Schneier, R Campeas, et al.
Psychosomatics|May 1, 1995
Late-stage neuropsychiatric Lyme borreliosis. Differential diagnosis and treatmentB A Fallon, M Schwartzberg, R Bransfield, et al.
The American Journal of Psychiatry|June 1, 1988
Epinephrine infusions in patients with social phobiaL A Papp, J M Gorman, M R Liebowitz, et al.
Journal of Clinical Psychopharmacology|June 1, 1990
Anxiety and depression: discrete diagnostic entities?M R Liebowitz, E Hollander, F Schneier, et al.
Biological Psychiatry|May 15, 1993
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorderE Hollander, D J Stein, C M DeCaria, et al.
The Journal of Nervous and Mental Disease|August 1, 1991
Cognitive-behavior therapy for panic disorder delivered by psychopharmacologically oriented cliniciansL A Welkowitz, L A Papp, M Cloitre, et al.
Biological Psychiatry|May 1, 1985
Biochemical effects of L-deprenyl in atypical depressivesM R Liebowitz, F Karoum, F M Quitkin, et al.
Pageof 23